Pathologic Intimal Thickening Plaque Phenotype: Not as Innocent as Previously Thought. A Serial 3D Intravascular Ultrasound Virtual Histology Study
Jazyk angličtina, španělština Země Španělsko Médium print-electronic
Typ dokumentu časopisecké články, multicentrická studie, randomizované kontrolované studie
PubMed
27615562
DOI
10.1016/j.rec.2016.04.058
PII: S1885-5857(16)30179-7
Knihovny.cz E-zdroje
- Klíčová slova
- Angina estable, Atherosclerotic plaque, Ecografía intravascular, Estudio de seguimiento, Follow-up study, Intravascular ultrasound, Lipid, Lípidos, Placa ateroesclerótica, Stable angina,
- MeSH
- anticholesteremika aplikace a dávkování MeSH
- aterosklerotický plát krev diagnóza farmakoterapie MeSH
- atorvastatin aplikace a dávkování MeSH
- časové faktory MeSH
- ezetimib aplikace a dávkování MeSH
- intervenční ultrasonografie metody MeSH
- kombinovaná farmakoterapie MeSH
- koronární cévy diagnostické zobrazování MeSH
- LDL-cholesterol krev MeSH
- lidé středního věku MeSH
- lidé MeSH
- následné studie MeSH
- nemoci koronárních tepen krev diagnóza farmakoterapie MeSH
- progrese nemoci MeSH
- stupeň závažnosti nemoci MeSH
- uživatelské rozhraní počítače * MeSH
- vztah mezi dávkou a účinkem léčiva MeSH
- zobrazování trojrozměrné MeSH
- Check Tag
- lidé středního věku MeSH
- lidé MeSH
- mužské pohlaví MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- multicentrická studie MeSH
- randomizované kontrolované studie MeSH
- Názvy látek
- anticholesteremika MeSH
- atorvastatin MeSH
- ezetimib MeSH
- LDL-cholesterol MeSH
INTRODUCTION AND OBJECTIVES: Pathologic intimal thickening (PIT) has been considered a benign plaque phenotype. We report plaque phenotypic changes in a baseline/follow-up intravascular ultrasound-based virtual histology study. METHODS: A total of 61 patients with stable coronary artery disease were analyzed from the HEAVEN trial (89 patients randomized between routine statin therapy vs atorvastatin 80mg and ezetimibe 10mg) with serial intravascular ultrasound imaging of nonculprit vessels. We compared changes in 693 baseline and follow-up 5-mm long segments in a novel risk score, Liverpool Active Plaque Score (LAPS), plaque parameters, and plaque composition. RESULTS: The PIT showed the highest increase of risk score and, with fibrous plaque, also the LAPS. Necrotic core (NC) abutting to the lumen increased in PIT (22 ± 51.7; P = .0001) and in fibrous plaque (17.9 ± 42.6; P = .004) but decreased in thin cap fibroatheroma (TCFA) (15.14 ± 52.2; P = .001). The PIT was the most likely of all nonthin cap fibroatheroma plaque types to transform into TCFA at follow-up (11% of all TCFA found during follow-up and 35.9% of newly-developed TCFA), but showed (together with fibrous plaque) the lowest stability during lipid-lowering therapy (24.7% of PIT remained PIT and 24.5% of fibrous plaque remained fibrous plaque). CONCLUSIONS: Over the 1-year follow-up, PIT was the most dynamic of the plaque phenotypes and was associated with an increase of risk score and LAPS (together with fibrous plaque), NC percentage (together with fibrous plaque) and NC abutting to the lumen, despite a small reduction of plaque volume during lipid-lowering therapy. The PIT was the main source for new TCFA segments.
Citace poskytuje Crossref.org